Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 10 2023
Historique:
medline: 6 10 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: epublish

Résumé

Multicenter clinical trials play a critical role in the translational processes that enable new treatments to reach all people and improve public health. However, conducting multicenter randomized clinical trials (mRCT) presents challenges. The Trial Innovation Network (TIN), established in 2016 to partner with the Clinical and Translational Science Award (CTSA) Consortium of academic medical institutions in the implementation of mRCTs, consists of 3 Trial Innovation Centers (TICs) and 1 Recruitment Innovation Center (RIC). This unique partnership has aimed to address critical roadblocks that impede the design and conduct of mRCTs, in expectation of accelerating the translation of novel interventions to clinical practice. The TIN's challenges and achievements are described in this article, along with examples of innovative resources and processes that may serve as useful models for other clinical trial networks providing operational and recruitment support. The TIN has successfully integrated more than 60 CTSA institution program hubs into a functional network for mRCT implementation and optimization. A unique support system for investigators has been created that includes the development and deployment of novel tools, operational and recruitment services, consultation models, and rapid communication pathways designed to reduce delays in trial start-up, enhance recruitment, improve engagement of diverse research participants and communities, and streamline processes that improve the quality, efficiency, and conduct of mRCTs. These resources and processes span the clinical trial spectrum and enable the TICs and RIC to serve as coordinating centers, data centers, and recruitment specialists to assist trials across the National Institutes of Health and other agencies. The TIN's impact has been demonstrated through its response to both historical operational challenges and emerging public health emergencies, including the national opioid public health crisis and the COVID-19 pandemic. The TIN has worked to reduce barriers to implementing mRCTs and to improve mRCT processes and operations by providing needed clinical trial infrastructure and resources to CTSA investigators. These resources have been instrumental in more quickly and efficiently translating research discoveries into beneficial patient treatments.

Identifiants

pubmed: 37796498
pii: 2810186
doi: 10.1001/jamanetworkopen.2023.36470
doi:

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2336470

Subventions

Organisme : NCATS NIH HHS
ID : U24 TR001597
Pays : United States
Organisme : NCATS NIH HHS
ID : U24 TR001608
Pays : United States
Organisme : NCATS NIH HHS
ID : U24 TR001609
Pays : United States
Organisme : NCATS NIH HHS
ID : U24 TR001579
Pays : United States

Investigateurs

Rachel Greenberg (R)
Kanecia Zimmerman (K)
Brian Smith (B)
Frank Rockhold (F)
Lori Poole (L)
Jesse Hickerson (J)
Eilene Pham (E)
Eve Marion (E)
Helen Boyle (H)
Vincent Miller (V)
Sonya Sutton (S)
Michelle Jones (M)
Princess Abbott-Grimes (P)
Nichole McBee (N)
Andrew Mould (A)
Lindsay Eyzaguirre (L)
Megan Singleton (M)
Janelle Maddox-Regis (J)
Shannon Hillery (S)
Angeline Nanni (A)
Meghan Hildreth (M)
Cecilia Pessoa-Gingerish (C)
Emily Bartlett (E)
Theodora Cohen (T)
Cortney Wieber (C)
Krista Vermillion (K)
Erin Rothwell (E)
Kevin Watt (K)
Kathy Sward (K)
John M VanBuren (JM)
Mary Pautler (M)
Marie Kay (M)
Jordan Bridges (J)
Krista Ellis (K)
Francis Sebahar (F)
Eun Hea Unsicker (EH)
Valeriya Vasenina (V)
Talmage Morris (T)
Michelle Aponte (M)
Ann Johnson (A)
Annie Risenmay (A)
Lisa Rigtrup (L)
Gary Henderson (G)
Ammon Leon Pate (AL)
Monse Lopez (M)
Leslie Boone (L)
Loretta Byrne (L)
Tara Helmer (T)
Maeve Tischbein (M)
Leah Dunkel (L)
Stephanie Mayers (S)
Kaysi Quarles (K)
Jasmine Bell (J)
Bridget Swindell (B)
Jabari Ichimura (J)
Devan Ray (D)
Caitlin Rantala (C)
Jessica Eidenmuller (J)
Emily Serdoz (E)
Natalie Dilts (N)
David Crenshaw (D)
Brooklyn Henderson (B)
Meghan Vance (M)
Delicia Burts (D)
Dione Grant (D)
Jahi Hamilton (J)
Matt Schorr (M)
Colleen Lawrence (C)
Meredith Bernui (M)
Taylor Budine (T)
Amna Baig (A)
Joseph Christodoulou (J)
Jodie Cohen (J)
Tiffany Chen (T)
Julia Dunagan (J)
Wendy Lloyd (W)

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Auteurs

Paul A Harris (PA)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.
Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

Sarah E Dunsmore (SE)

National Center for Advancing Translational Sciences, Bethesda, Maryland.

Jane C Atkinson (JC)

National Center for Advancing Translational Sciences, Bethesda, Maryland.

Daniel Kelly Benjamin (DK)

Duke University School of Medicine, Durham, North Carolina.
Duke Clinical Research Institute, Durham, North Carolina.

Gordon R Bernard (GR)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

J Michael Dean (JM)

University of Utah Health, Salt Lake City.

Jamie P Dwyer (JP)

University of Utah Health, Salt Lake City.
Utah Clinical and Translational Sciences Institute, Salt Lake City.

Daniel F Ford (DF)

Johns Hopkins Institute for Clinical and Translational Research, Baltimore, Maryland.

Harry P Selker (HP)

Department of Medicine, Tufts University, Boston, Massachusetts.
Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

Salina P Waddy (SP)

National Center for Advancing Translational Sciences, Bethesda, Maryland.

Kenneth L Wiley (KL)

National Center for Advancing Translational Sciences, Bethesda, Maryland.

Consuelo H Wilkins (CH)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee.

Sarah K Cook (SK)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.

Jeri S Burr (JS)

University of Utah Health, Salt Lake City.

Terri L Edwards (TL)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.

Jacqueline Huvane (J)

Duke Clinical Research Institute, Durham, North Carolina.

Nan Kennedy (N)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.

Karen Lane (K)

Johns Hopkins Institute for Clinical and Translational Research, Baltimore, Maryland.
Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ryan Majkowski (R)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Sarah Nelson (S)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.

Marisha E Palm (ME)

Department of Medicine, Tufts University, Boston, Massachusetts.
Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

Mary Stroud (M)

Vanderbilt Institute for Clinical and Translational Research, Nashville, Tennessee.

Dixie D Thompson (DD)

University of Utah Health, Salt Lake City.
Utah Clinical and Translational Sciences Institute, Salt Lake City.

Linda Busacca (L)

Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, New York.

Mitchell S V Elkind (MSV)

Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York.

Robert P Kimberly (RP)

Center for Clinical and Translational Science, University of Alabama at Birmingham.

Muredach P Reilly (MP)

Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, New York.

Daniel F Hanley (DF)

Johns Hopkins Institute for Clinical and Translational Research, Baltimore, Maryland.
Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH